Oncolytic Adenovirus Coding for a Variant Interleukin 2 (vIL-2) Cytokine Re-Programs the Tumor Microenvironment and Confers Enhanced Tumor Control

Show full item record



Permalink

http://hdl.handle.net/10138/332422

Citation

Quixabeira , D C A , Zafar , S , Santos , J M , Cervera-Carrascon , V , Havunen , R , Kudling , T V , Basnet , S , Anttila , M , Kanerva , A & Hemminki , A 2021 , ' Oncolytic Adenovirus Coding for a Variant Interleukin 2 (vIL-2) Cytokine Re-Programs the Tumor Microenvironment and Confers Enhanced Tumor Control ' , Frontiers in Immunology , vol. 12 , 674400 . https://doi.org/10.3389/fimmu.2021.674400

Title: Oncolytic Adenovirus Coding for a Variant Interleukin 2 (vIL-2) Cytokine Re-Programs the Tumor Microenvironment and Confers Enhanced Tumor Control
Author: Quixabeira, Dafne C.A.; Zafar, Sadia; Santos, Joao M.; Cervera-Carrascon, Victor; Havunen, Riikka; Kudling, Tatiana V.; Basnet, Saru; Anttila, Marjukka; Kanerva, Anna; Hemminki, A.
Contributor organization: Research Programs Unit
TRIMM - Translational Immunology Research Program
University of Helsinki
HUS Comprehensive Cancer Center
Department of Pathology
Department of Oncology
Medicum
HUS Gynecology and Obstetrics
Akseli Eetu Hemminki / Principal Investigator
Clinicum
Department of Obstetrics and Gynecology
Date: 2021-05-18
Language: eng
Number of pages: 13
Belongs to series: Frontiers in Immunology
ISSN: 1664-3224
DOI: https://doi.org/10.3389/fimmu.2021.674400
URI: http://hdl.handle.net/10138/332422
Description: cited By 0
Subject: 3122 Cancers
3111 Biomedicine
oncolytic virus
IL-2 variant
anti-tumor immunity
tumor microenvironment (TME)
virotherapy in cancer
HIGH-DOSE INTERLEUKIN-2
CELLS
Peer reviewed: Yes
Rights: cc_by
Usage restriction: openAccess
Self-archived version: publishedVersion


Files in this item

Total number of downloads: Loading...

Files Size Format View
fimmu_12_674400.pdf 2.483Mb PDF View/Open

This item appears in the following Collection(s)

Show full item record